Elyashiv O, et al. – The purpose of the present study is to assess the safety of this procedure in regard to residual uterine pathology. These outcomes show that hysteroscopic assessment of the uterine cavity and polyp resection are not enough for the eradication of pre–malignant and malignant endometrial lesions. This option ought to be reserved for well–selected cases such as for fertility preservation and for the patient with surgical risk factors that after the hysteroscopic polypectomy will receive further medical treatment.

Methods

• For this research, they designed a retrospective chart review (Canadian Task Force classification II-2).
• This study was conducted at the university hospital.
• Amid the years 1998–2016, total 1766 women who underwent hysteroscopic polypectomy.

Results

• 43 women (2.4%) were diagnosed with pre–malignant and malignant polyps: 21 with EC and 22with CAH.
• 34 women (79.0%) underwent hysterectomy and were incorporated into the study group.
• 62 years (range 35–83 years) was the median age. In this study, most women (79.4%) presented with postmenopausal bleeding or menorrhagia.
• In 13 patients (38.2%) more than one polyp was removed.
• The median size of the polyps was 2 cm (range 1–4cm).
• In 27 women, there were no other visible endometrial findings amid the hysteroscopy except for the removed polyp.
• However, in 24 of them (88.9%) residual CAH or EC was present in the hysterectomy specimen, mostly (55.6%) as multifocal lesions.